6:33 am BioCryst Pharm announces Nature publication demonstrating efficacy of BCX4430 in a non-human primate model of filovirus infection; broad spectrum activity shown against multiple RNA virus biothreats
View todays social media effects on BCRX
View the latest stocks trending across Twitter. Click to view dashboard
See who BioCryst is hiring next, click here to view
